Enhanced seasonal malaria vaccination in Nigeria (ENHANCE)
Malaria Consortium is assessing the feasibility, coverage, health impact and cost-effectiveness of a hybrid delivery model for malaria vaccines in Kebbi state, Nigeria, in collaboration with federal and state health authorities, including the National Primary Health Care Development Agency and the National Malaria Elimination Programme. This implementation research study is designed to identify the most effective strategies for maximising the health impact of malaria vaccines in areas of highly seasonal transmission through improved coverage.
Start date
01/04/2025
End date
31/12/2025
Country/
Countries
Countries
Africa >
Nigeria
Funder
Gavi, the Vaccine Alliance
Partners
Kebbi State Government, National Malaria Elimination Programme, National Primary Health Care Development Agency
